Giant cell arteritis: Diagnosis and therapeutic management

被引:11
|
作者
Gonzalez-Gay M.A. [1 ]
Garcia-Porrua C. [1 ]
Miranda-Filloy J.A. [1 ]
机构
[1] Rheumatology Division, Hospital Xeral-Calde, Lugo
关键词
Giant Cell Arteritis; Temporal Artery; Polymyalgia Rheumatica; Temporal Artery Biopsy; Halo Sign;
D O I
10.1007/s11926-006-0013-7
中图分类号
学科分类号
摘要
Giant cell arteritis (GCA) is the most common systemic vasculitis in the elderly in Western countries. Anemia and very high erythrocyte sedimentation rates are associated with lower incidence of severe ischemic events. Temporal artery biopsy is the gold standard in the diagnosis of GCA. A threshold size of 1 cm of post-formalin fixed segment of the temporal artery was associated with increased diagnostic yield of GCA. Other tools such as ultrasound, MRI, and fluorodeoxyglucose positron emission tomography are useful in the diagnosis of GCA. Corticosteroids are the cornerstone treatment of GCA. Studies using other drugs have yielded contradictory results. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:299 / 302
页数:3
相关论文
共 50 条
  • [41] Clinical Diagnosis and Management of Large Vessel Vasculitis: Giant Cell Arteritis
    Chatterjee, Soumya
    Flamm, Scott D.
    Tan, Carmela D.
    Rodriguez, E. Rene
    [J]. CURRENT CARDIOLOGY REPORTS, 2014, 16 (07)
  • [42] Diagnosis and management of giant cell arteritis: an Asia-Pacific perspective
    Ninan, Jem V.
    Lester, Susan
    Hill, Catherine L.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 : 28 - 40
  • [43] Large-vessel giant cell arteritis: diagnosis, monitoring and management
    Koster, Matthew J.
    Matteson, Eric L.
    Warrington, Kenneth J.
    [J]. RHEUMATOLOGY, 2018, 57 : 32 - 42
  • [44] Current therapeutic options for giant cell arteritis
    Wipfler-Freissmuth, E.
    Loock, J.
    Moosig, F.
    Dejaco, C.
    Duftner, C.
    Schirmer, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (02): : 132 - +
  • [45] GIANT-CELL ARTERITIS - THERAPEUTIC PERSPECTIVES
    ROMA, JC
    CUETO, FB
    [J]. MEDICINA CLINICA, 1985, 85 (02): : 61 - 62
  • [46] Update on the management of giant cell arteritis
    Roberts, Janet
    Clifford, Alison
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2017, 8 (4-5) : 69 - 79
  • [47] Updates in the Management of Giant Cell Arteritis
    Baig, Aqil
    Gafoor-Haseeb, Sana
    Goldsher, Jay
    Siddique, Faizah
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2024, 24 (08) : 285 - 291
  • [48] Steroid management in giant cell arteritis
    Chan, CCK
    Paine, M
    O'Day, J
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (09) : 1061 - 1064
  • [49] AUDIT ON THE MANAGEMENT OF GIANT CELL ARTERITIS
    Cutts, Louise V.
    Putchakayala, Kiran
    [J]. RHEUMATOLOGY, 2014, 53 : 112 - 112
  • [50] Polymyalgia Rheumatica and Giant Cell Arteritis in Older Patients Diagnosis and Pharmacological Management
    Schmidt, Jean
    Warrington, Kenneth J.
    [J]. DRUGS & AGING, 2011, 28 (08) : 651 - 666